Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: Susceptibility for rheumatoid arthritis

Tissue Antigens

Volumn 72, Issue 4, 2008, Pages 342-346

  Park, K S ^a   Park, J H ^a   Song, Y W ^b  

^a Sungshin Women's University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

NKG2A; NKG2C; NKG2D; Rheumatoid arthritis

Indexed keywords

ALANINE; ANTINUCLEAR ANTIBODY; MEMBRANE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; NATURAL KILLER CELL RECEPTOR NKG2D; PHENYLALANINE; RHEUMATOID FACTOR; SERINE; THREONINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; BONE EROSION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RHEUMATOID ARTHRITIS; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NATURAL KILLER CELL; RHEUMATOID FACTOR;

EID: 51649117901     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2008.01110.x     Document Type: Article

References (25)

1. Coppieters K, Dewint P, Van Beneden K et al. NKT cells: manipulable managers of joint inflammation. Rheumatology 2007 : 46 : 565 71.
2. Groh V, Bruhl A, El-Gabalawy H, Nelson JL, Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc Natl Acad Sci U S A 2003 : 100 : 9452 7.
3. Namekawa T, Snyder MR, Yen JH et al. Killer cell activating receptors function as costimulatory molecules on CD4+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000 : 165 : 1138 45.
4. Warrington KJ, Takemura S, Goronzy JJ, Weyand CM. CD4+CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum 2001 : 44 : 13 20.
5. Lanier LL. NK cell recognition. Annu Rev Immunol 2005 : 23 : 225 74.
6. Freishtat RJ, Mitchell LW, Ghimbovschi SD, Meyers SB, Hoffman EP. NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes. Hum Immunol 2005 : 66 : 1223 34.
7. Borrego F, Masilamani M, Kabat J, Sanni TB, Coligan JE. The cell biology of human natural killer cell CD94/NKG2A inhibitory receptor. Mol Immunol 2005 : 42 : 485 8.
8. Lieto LD, Maasho K, West D, Borrego F, Coligan JE. The human CD94 gene encodes multiple, expressible transcripts including a new partner of NKG2A/B. Genes Immun 2006 : 7 : 36 43.
9. Yen JH, Moore BE, Nakajima T et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J Exp Med 2001 : 193 : 1159 67.
10. Yen JH, Lin CH, Tsai WC et al. Killer-cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis. Scand J Rheumatol 2006 : 35 : 124 7.
11. Guma M, Busch LK, Salazar-Fontana LI et al. The CD94/NKG2C killer lectin-like receptor constitutes an alternative activation pathway for a subset of CD8+ T cells. Eur J Immunol 2005 : 35 : 2071 80.
12. Arlettaz L, Villard J, deRam C et al. Activating CD94:NKG2C and inhibitory CD94:NKG2A receptors are expressed by distinct subsets of committed CD8+ TCR alphabeta lymphocytes. Eur J Immunol 2004 : 34 : 3456 64.
13. Ortega C, Romero P, Palma A et al. Role for NKG2-A and NKG2-C surface receptors in chronic CD4+ T-cell responses. Immunol Cell Biol 2004 : 82 : 587 95.
14. Bauer S, Groh V, Wu J et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999 : 285 : 727 9.
15. Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR, Spies T. Costimulation of CD8 αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2001 : 2 : 255 60.
16. Eagle RA, Traherne JA, Ashiru O, Wills MR, Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol 2006 : 67 : 159 69.
17. Glienke J, Sobanov Y, Brostjan C et al. The genomic organization of NKG2C, E, F, and D receptor genes in the human natural killer gene complex. Immunogenetics 1998 : 48 : 163 73.
18. Cornelis F, Faure S, Martinez M et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci U S A 1998 : 95 : 10746 50.
19. Gunturi A, Berg RE, Forman J. The role of CD94/NKG2 in innate and adaptive immunity. Immunol Res 2004 : 30 : 29 34.
20. Amett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988 : 31 : 315 34.
21. Hayashi T, Imai K, Morishita Y, Hayashi I, Kusunoki Y, Nakachi K. Identification of the NKG2D haplotypes associated with natural cytotoxic activity of peripheral blood lymphocytes and cancer immunosurveillance. Cancer Res 2006 : 66 : 563 70.
22. Gornzy JJ, Weyand CM. T-cell regulation in rheumatoid arthritis. Curr Opin Rheumatol 2004 : 16 : 212 7.
23. McMahon CW, Raulet DH. Expression and function of NK cell receptors in CD8(+) T cells. Curr Opin Immunol 2001 : 13 : 465 70.
24. De Matos CT, Berg L, Michaelsson J, Fellander-Tsai L, Karre K, Soderstrom K. Activating and inhibitory receptors on synovial fluid natural killer cells of arthritis patients: role of CD94/NKG2A in control of cytokine secretion. Immunology 2007 : 122 : 291 301.
25. Groh V, Smythe K, Dai Z, Spies T. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol 2006 : 7 : 755 62.